promethazine has been researched along with Agoraphobia in 1 studies
Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thirty-seven outpatients with panic disorder and agoraphobia (PDA) were treated with imipramine (75-150 mg/day) in an 8-week open, prospective trial." | 5.09 | Application of a new statistical approach to evaluate a clinical trial with panic disorder patients. ( Bandelow, B; Beinroth, D; Broocks, A; Brunner, E; Hajak, G; Pralle, L; Rüther, E, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandelow, B | 1 |
| Brunner, E | 1 |
| Beinroth, D | 1 |
| Pralle, L | 1 |
| Broocks, A | 1 |
| Hajak, G | 1 |
| Rüther, E | 1 |
1 trial available for promethazine and Agoraphobia
| Article | Year |
|---|---|
Application of a new statistical approach to evaluate a clinical trial with panic disorder patients.
Topics: Adult; Agoraphobia; Clinical Trials as Topic; Desensitization, Psychologic; Female; Humans; Imiprami | 1999 |